Unlikely to cause harm — often a labeling or packaging issue.
Failed stability specifications
| Brand name | AZACITIDINE |
| Generic name | AZACITIDINE |
| Active ingredient(s) | AZACITIDINE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-305-62 |
| Full product label | Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-305-62 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | USA Nationwide |
| Quantity | 68061 vials |
| Recall initiated | 2022-01-19 |
| Report date | 2022-03-02 |
| Recall completed | 2022-12-13 |
| Recall number | D-0575-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗